Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Location
Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Telephone Numbers
Customer Service: (800) 227-6666 / (650) 697-3600
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G145759-10 | 10 µg | $372 |
| LS-G145759-1 | 1 mg | $2,880 |
Human CXCL3 / GRO Gamma Protein (Recombinant) - LS-G145759
Human CXCL3 / GRO Gamma Protein (Recombinant) - LS-G145759
Description:
CXCL3 / GRO Gamma Protein LS-G145759 is a Recombinant Human CXCL3 / GRO Gamma. It is biologically active and is low in endotoxin; Less than 1 EU/µg (determined by LAL method). For Research Use Only
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Description:
CXCL3 / GRO Gamma Protein LS-G145759 is a Recombinant Human CXCL3 / GRO Gamma. It is biologically active and is low in endotoxin; Less than 1 EU/µg (determined by LAL method). For Research Use Only
Specifications
Type
Recombinant Protein
Target
CXCL3 / GRO Gamma
Synonyms
CXCL3 | C-X-C motif chemokine 3 | GRO3 oncogene | Growth-regulated protein gamma | GRO3 | GRO-gamma | GRO-gamma(1-73) | MGSA gamma | MIP2B | MIP-2b | MIP2-beta | CINC-2b | GROg | SCYB3 | Small inducible cytokine b3
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Predicted Molecular Weight
7.9 kDa
AA Sequence
ASVVTELRCQCLQTLQGIHLKNIQSVNVRSPGPHCAQTEVIATLKNGKKACLNPASPMVQKIIEKILNKGSTN
Source Species
E. coli
Purification
Greater than 97% by SDS-PAGE and HPLC
Usage Summary
A single non-glycosylated polypeptide chain containing 73 amino acids.
Bio-Activity
Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human CXCR2 transfected human 293 cells is in a concentration range of 10-100 ng/ml.
Endotoxin
Less than 1 EU/µg (determined by LAL method).
Presentation
Lyophilized from a 0.2 um filtered concentrated solution in 20 mM PB, pH 7.4, 50 mM NaCl
Reconstitution
Briefly centrifuge prior to opening. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml.
Storage
Store lyophilized at 2°C to 8°C for short term storage. Store lyophilized at -20°C for long term storage. Store reconstituted at 2°C to 8°C for up to 1 week. Aliquot and store reconstituted at -20°C to -70°C. Avoid repeated freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About CXCL3 / GRO Gamma
Publications (0)
Customer Reviews (0)
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/21/2024
Date Requested: 12/21/2024
